HealthNews
Game-Changing Milestone: FDA Approves First Gene Interventions to Treat Patients with Sickle Cell Disease
The FDA(Food and Drug Administration) has approved two remarkable gene therapies, Casgevy and Lyfgenia, to manage sickle cell disease (SCD). In a press...